A Study for Cerebral Open Flow Microperfusion

NANot yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 1, 2026

Primary Completion Date

February 29, 2028

Study Completion Date

October 31, 2028

Conditions
GliomaGlioblastoma
Interventions
DEVICE

Cerebral open flow microperfusion

"Patients will undergo intra-operative microperfusion using Joanneum Research's cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump. This process utilizes a probe (catheter) inserted into the parenchyma to collect analytes of any size and polarity from the microenvironment. The microperfusion pump peristaltically pushes and pulls perfusate with no net fluid-exchange when the pump heads are set at equal flow rates. As perfusate enters the tip of the microperfusion catheter, analytes are exchanged based on a gradient between the interstitial fluid and the perfusate. The sample is then recovered via the pull portion of the peristaltatic microperfusion pump, enabling constant sampling volumes and preventing loss of the perfusate into the tissue.~The duration is 60-80 minutes (dependent on the speed of progress resecting portions of the tumor without catheters)"

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT07089758 - A Study for Cerebral Open Flow Microperfusion | Biotech Hunter | Biotech Hunter